MAY 16, 2018 6:30 AM PDT

Ketogenic Diet Has Anti-Tumor Effects

WRITTEN BY: Mauri Brueggeman

What is up with the ketogenic diet?  Individuals struggling with their size and health have utilized it successfully to lose large amounts of weight in relatively short spans of time.  The ketogenic diet (KD) is a high-fat, low-carbohydrate, moderate-protein method of eating to utilize the body’s ability to use fat for energy, rather than using consumed glucose in multiple forms including carbohydrates.  The body enters a state of ketosis whereby body fat is burned for cellular energy and produces ketones.  After learning more about this eating method, researchers began to look at the biochemical mechanisms of this ketogenic process in the body; the impact on cells is very positive.  Healthy cells can produce ATP via oxidative phosphorylation instead of via glycolysis.  Cancerous cells, on the other hand, cannot generate energy without the glycolytic pathway and thus, do not produce the energy needed to survive in the KD environment.  The Warburg effect outlines the biochemical phenomenon where cancer cells use glycolysis to produce energy rather than alternative methods of ATP production.  It is postulated that the Warburg Effect supports the biosynthetic requirements of uncontrolled proliferation, according to Liberti and Locasale (Trends Biochem Sci, 2016).  Cancerous cells have also been shown to have an inability to process ketone bodies due to mitochondrial dysfunction.  The KD can therefore be a dietary option for cancer patients to reduce their blood glucose levels, thus starving cancerous cells of their energy source.  In addition, lowering blood glucose levels triggers lowered levels of insulin and growth factors which have been shown to be drivers in cancer progression resulting in energy depleted cancer cells with low drive to proliferate and grow.

One study published this year in the journal Aging outlined their proposal and evaluation of preclinical study data on this topic.  The literature supports the hypothesis that a KD can have an anti-tumor effect, but it may be dependent on the type of cancer involved. KD has been studied with neuroblastoma patients and been shown to reduce growth rates.  One study suggested the difficulty in utilizing a KD in some cancer patients with cachexia so proposed an alternative KD diet, termed ad libitum KD with 25% medium-chain triglycerides and 75% long-chain triglycerides produced a better anti-tumor effect.  Individual optimization may be necessary for a provider and patient based on their cancer diagnosis and tumor profile.  With the use of data analytics and computational oncology to provide toolkits and databases for tumor profiles and precision medicine suggestions, this information could also be included.

Randomized clinical trials have not been completed to evaluate this approach but of the clinical studies in the literature, results are promising and something to consider for patients.

This TedTalk is done by a researcher in Florida who is currently working on ketogenic agents and alternative energy sources to reduce cancer load. 

Sources: Aging, Trends in Biochemical Science, Redox Biology,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
SEP 14, 2020
Cancer
We are too uneducated on the risks of colon cancer
SEP 14, 2020
We are too uneducated on the risks of colon cancer
A study conducted by researchers from Florida Atlantic University's Schmidt College of Medicine suggests that too ma ...
SEP 30, 2020
Cancer
Chemokines Could be the Key in Controlling Glioma Stem Cells
SEP 30, 2020
Chemokines Could be the Key in Controlling Glioma Stem Cells
The transformation of a healthy cell into a cancerous one often comes with a slew of cellular signaling changes.  T ...
OCT 11, 2020
Cancer
Targeting neoantigens to improve immunotherapies
OCT 11, 2020
Targeting neoantigens to improve immunotherapies
Neoantigens are extremely small biomarkers forming from cancer mutations that demonstrate the presence of cancerous cell ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
NOV 26, 2020
Clinical & Molecular DX
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
NOV 26, 2020
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
New research has revealed that exposure to radiation from diagnostic procedures such as X-rays could contribute to an el ...
NOV 23, 2020
Cancer
Where are the geographic hotspots of high mortality rates for women with colorectal cancer?
NOV 23, 2020
Where are the geographic hotspots of high mortality rates for women with colorectal cancer?
A study published in Clinical and Translational Gastroenterology highlights the risk disparities in death rates fro ...
Loading Comments...